Insider Trading & Ownership of Thomas Ryll
-
Location
-
Waltham, MA
-
Summary
-
The estimated net worth of Thomas Ryll is at least $2,510,923 dollars as of 02 Jul 2021. Thomas Ryll is the SVP, Technical Operations of ImmunoGen, Inc. and owns shares of ImmunoGen, Inc. stock worth about $2.51M.
-
Signature
-
/s/ Joseph J. Kenny, attorney in fact
Follow Filing Activity
Follow Thomas Ryll and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Quick Takeaways
- Thomas Ryll has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $2,510,923.
- Recent insider filing activity is available below.
What Changed
- Largest disclosed position: ImmunoGen, Inc. ($2,510,923).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing
Continue ownership research
Ownership of Thomas Ryll
Insider Transactions Reported by Thomas Ryll:
| Sym |
Company |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.